Among these markers, αSMA is the most commonly used CAF marker, and a high abundance of αSMA-expressing CAFs in NSCLC tissues has been associated with a poor prognosis [23,24,25]. The gene discussed is ACTA1; the disease is non-small cell lung carcinoma.